LFMD Stock Overview
Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
My Notes
Capture your thoughts, links and company narrative
LifeMD, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.04 |
| 52 Week High | US$12.88 |
| 52 Week Low | US$3.99 |
| Beta | 1.42 |
| 1 Month Change | -7.01% |
| 3 Month Change | 2.65% |
| 1 Year Change | -41.26% |
| 3 Year Change | 16.67% |
| 5 Year Change | 681.64% |
| Change since IPO | 34.40% |
Recent News & Updates
LifeMD, Inc.'s (NASDAQ:LFMD) Intrinsic Value Is Potentially 82% Above Its Share Price
Dec 06
LifeMD: A Story I Want A Small Piece Of
Dec 04LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story
Nov 09LifeMD: Are The Commons Too Cheap?
Sep 23Recent updates
LifeMD, Inc.'s (NASDAQ:LFMD) Intrinsic Value Is Potentially 82% Above Its Share Price
Dec 06LifeMD: A Story I Want A Small Piece Of
Dec 04LifeMD, Inc.'s (NASDAQ:LFMD) Shares Leap 31% Yet They're Still Not Telling The Full Story
Nov 09LifeMD: Are The Commons Too Cheap?
Sep 23LifeMD: Selling WorkSimpli Could Be A Catalyst
Sep 10It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks
Aug 16LifeMD: High Growth GLP-1 Telehealth Play At A Discount
Jul 31LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare
Jun 11LifeMD: Moving Towards Profitability
May 22Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?
Apr 25Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely
Mar 30LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program
Mar 13LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability
Jan 22LifeMD: A GLP-1 Play With A Kicker
Jan 11Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?
Jan 05Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper
Jan 05Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?
Dec 03Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump
Apr 17Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week
Nov 17LifeMD launches at-home screening kits for breast, colon cancers
Sep 14LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M
Aug 11Shareholder Returns
| LFMD | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -11.4% | -3.7% | -3.5% |
| 1Y | -41.3% | 0.7% | 22.1% |
Return vs Industry: LFMD underperformed the US Healthcare Services industry which returned 0.7% over the past year.
Return vs Market: LFMD underperformed the US Market which returned 22.1% over the past year.
Price Volatility
| LFMD volatility | |
|---|---|
| LFMD Average Weekly Movement | 13.4% |
| Healthcare Services Industry Average Movement | 9.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: LFMD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: LFMD's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 209 | Justin Schreiber | lifemd.com |
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more.
LifeMD, Inc. Fundamentals Summary
| LFMD fundamental statistics | |
|---|---|
| Market cap | US$212.23m |
| Earnings (TTM) | -US$25.61m |
| Revenue (TTM) | US$193.06m |
1.1x
P/S Ratio-8.5x
P/E RatioIs LFMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LFMD income statement (TTM) | |
|---|---|
| Revenue | US$193.06m |
| Cost of Revenue | US$19.99m |
| Gross Profit | US$173.06m |
| Other Expenses | US$198.68m |
| Earnings | -US$25.61m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.59 |
| Gross Margin | 89.64% |
| Net Profit Margin | -13.27% |
| Debt/Equity Ratio | -306.1% |
How did LFMD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 02:50 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
LifeMD, Inc. is covered by 12 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| William Wood | B. Riley Securities, Inc. |
| Neil Chatterji | B. Riley Securities, Inc. |
| David Larsen | BTIG |